Literature DB >> 19704778

Improving biomedical imaging with gold nanocages.

Younan Xia1, Sara E Skrabalak.   

Abstract

The new class of contrast enhancement agents can be precisely tuned to aid in vivo photoacoustic tomography.

Entities:  

Year:  2008        PMID： 19704778      PMCID： PMC2729253          DOI： 10.1117/2.1200805.1135

Source DB:  PubMed          Journal:  SPIE Newsroom        ISSN： 1818-2259


  5 in total

Review 1.  Gold nanostructures: engineering their plasmonic properties for biomedical applications.

Authors:  Min Hu; Jingyi Chen; Zhi-Yuan Li; Leslie Au; Gregory V Hartland; Xingde Li; Manuel Marquez; Younan Xia
Journal:  Chem Soc Rev       Date:  2006-09-06       Impact factor: 54.564

2.  Gold Nanocages for Biomedical Applications.

Authors:  Sara E Skrabalak; Jingyi Chen; Leslie Au; Xianmao Lu; Xingde Li; Younan Xia
Journal:  Adv Mater       Date:  2007-10-17       Impact factor: 30.849

3.  Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent.

Authors:  Xinmai Yang; Sara E Skrabalak; Zhi-Yuan Li; Younan Xia; Lihong V Wang
Journal:  Nano Lett       Date:  2007-11-20       Impact factor: 11.189

4.  Gold nanocages: synthesis, properties, and applications.

Authors:  Sara E Skrabalak; Jingyi Chen; Yugang Sun; Xianmao Lu; Leslie Au; Claire M Cobley; Younan Xia
Journal:  Acc Chem Res       Date:  2008-12       Impact factor: 22.384

5.  Facile synthesis of Ag nanocubes and Au nanocages.

Authors:  Sara E Skrabalak; Leslie Au; Xingde Li; Younan Xia
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491
  5 in total
  2 in total

Review 1.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

2.  Enhanced photoluminescence stability of CdS nanocrystals through a zinc acetate reagent.

Authors:  M Banski; M Chrzanowski; G Zatryb; J Misiewicz; A Podhorodecki
Journal:  RSC Adv       Date:  2018-07-16       Impact factor: 4.036
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.